Dr. Alfayez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 Holcombe Blvd
Leukemia Department
Houston, TX 77030
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2019
St Elizabeth's Medical CenterResidency, Internal Medicine, 2011 - 2014
OtherClass of 2008
Certifications & Licensure
MA State Medical License 2014 - 2021
Publications & Presentations
PubMed
- Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy.Jessica L Root, Poonam N Desai, Christopher Ly, Bofei Wang, Fatima Zahra Jelloul
Cancer Research Communications. 2024-03-06 - Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin.Riad El Fakih, Momen Nassani, Walid Rasheed, Amr Hanbali, Fahad Almohareb
Transplantation and Cellular Therapy. 2024-03-01 - Cigarette smoke exposure accelerates AML progression in FLT3-ITD models.Mary Figueroa, Huaxian Ma, Mansour Alfayez, Daniel Enrique Morales-Mantilla, Fei Wang
Blood Advances. 2023-11-14
Abstracts/Posters
- Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo + Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Prospective, Phase 2 StudyMansour Alfayez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Activity of Multiple Targetable Therapies in FLT3-Mutated (mu) Acute Myeloid Leukemia (AML) Patients (pts) with Concurrent Isocitrate Dehydrogenase Mutation (IDHm)Mansour Alfayez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Comprehensive Analysis of Genotype and Prior Exposures in Therapy-Related Myeloid Neoplasms (t-MNs)Mansour Alfayez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Association of smoking with poor risk ELN 2017, cytogenetics/molecular profile, and survival outcomes in acute myeloid leukemia.2019 ASCO Annual Meeting - 6/1/2019
- Characteristics and outcomes of myelodysplastic syndrome (MDS) with chromosome (chr)3q abnormalities.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Impact of variant allele frequency of mutant PTPN11 in AML: Single institution experience of 122 patients.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
